Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM · NASDAQ Global Market
+$3.89 today
Vol 1.46M · Avg 0.95M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+113.07%
Period High
$111.39
Period Low
$48.39
Latest
$107.13
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Belite Bio, Inc
NASDAQ:BLTE
$6.01B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.95B
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
$5.32B
Travere Therapeutics, Inc.
NASDAQ:TVTX
$5.10B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.68B
Telix Pharmaceuticals Limited
NASDAQ:TLX
$3.39B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.27B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.72B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.96B
What is the latest MIRM filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does MIRM have?
Intrinsic Alpha currently shows 20 recent filings for MIRM.
Explore More
Continue the stock analysis
Jump to another research area for this company.